Advertisement

Topics

Akebia Therapeutics Appoints Cynthia Smith to Its Board of Directors

16:05 EDT 28 Aug 2018 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company focused on delivering innovative therapies to patients with kidney disease through the biology of hypoxia-inducible factor (HIF), today announced the a...

Other Sources for this Article

Akebia Therapeutics Contact
John Garabo, 617-844-6130
Director, Corporate Communications
jgarabo@akebia.com

NEXT ARTICLE

More From BioPortfolio on "Akebia Therapeutics Appoints Cynthia Smith to Its Board of Directors"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Nephrology - kidney function
Nephrology is a specialty of medicine and pediatrics that concerns itself with the study of normal kidney function, kidney problems, the treatment of kidney problems and renal replacement therapy (dialysis and kidney transplantation). Systemic conditions...

Renal disease
Chronic kidney disease (CKD), also known as chronic renal disease, is a progressive loss in renal function over a period of months or years. The symptoms of worsening kidney function are non-specific, and might include feeling generally unwell and experi...